Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ASCO 2017: Round up

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 06.06.17
Views: 6318

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan

Dr Gyawali speaks with ecancer Medical Reporter Will Davies at ASCO 2017 about his conference highlights.

For more from Dr Ethan Basch on improving survival and quality of life with a web-based patient feedback platform, click here.

Dr Jane Beith, Dr Viviane Hess and Dr Gary Rodin spoke with ecancer about their psychological interventions improving patient quality of life as well.

Reducing oxaliplatin duration in the SCOT trial, part of the with IDEA group, was discussed by Dr Tim Iveson here.

Prof Pier Franco Conte and Prof Valentina Guarneri both discussed the ShortHER trial of reduced trastuzumab.

Shorter durations of ADT with chemo were discussed by Prof Abdenour Nabid, here.

For more on STAMPEDE and LATITUDE, watch our expert discussion.

Dr Matteo Lambertini spoke about breast cancer relapse and pregnancy here.


Related videos

follow us

Breast Cancer CDK 4/6

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation